STOCK TITAN

Invitation to the presentation of Elekta's second quarter 2021/22

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Elekta will present its second quarter 2021/22 results on November 25 at 10:00 a.m. CET, following the release of its interim report at 7:30 a.m. CET on the same day. The presentation will be conducted by President and CEO Gustaf Salford and CFO Johan Adebäck, including a Q&A session. Participants can join via a phone conference or watch the webcast. Elekta is a leader in precision radiation therapy, committed to innovative solutions in cancer care.

Positive
  • Scheduled presentation for Q2 results may enhance investor confidence.
  • Leadership presentation could provide insights into strategic direction.
Negative
  • None.

STOCKHOLM, Nov. 4, 2021 /PRNewswire/ --Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the second quarter 2021/22 at 10:00 a.m. CET on November 25. The interim report for the second quarter will be published at 7:30 a.m. CET on the same day.

The company's development will be presented by Elekta's President and CEO, Gustaf Salford, together with CFO, Johan Adebäck. After the presentation, held in English, a Q&A session will follow.

The presentation will be broadcast live on the web. It will be necessary to join the phone conference if you plan to ask questions. A recording of the webcast can be found on Elekta's website after the call.

Welcome!

Time: Thursday, November 25, at 10:00 a.m. CET

Telephone numbers to join phone conference:
UK: +44 333 300 9035 
USA: +1 646 722 4902
Sweden: +46 8 566 427 06 

Webcast: https://elekta-qreports.creo.se/211125

# # #

For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com
Time zone: CET (Central European Time)

About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don't just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.

CONTACT:

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/elekta/r/invitation-to-the-presentation-of-elekta-s-second-quarter-2021-22,c3446424

The following files are available for download:

https://mb.cision.com/Main/35/3446424/1490902.pdf

Invitation to the presentation of Elekta's Q2_2021-22

Cision View original content:https://www.prnewswire.com/news-releases/invitation-to-the-presentation-of-elektas-second-quarter-202122-301416187.html

SOURCE Elekta

FAQ

When will Elekta release its second quarter results for 2021/22?

Elekta will release its second quarter results on November 25, 2021, at 7:30 a.m. CET.

Who will present Elekta's second quarter results?

President and CEO Gustaf Salford and CFO Johan Adebäck will present the results.

What time is Elekta's Q2 presentation scheduled for?

The presentation is scheduled for November 25, 2021, at 10:00 a.m. CET.

How can I access Elekta's Q2 presentation?

The presentation will be available via a live webcast and can also be accessed through a phone conference.

Where can I find the recording of Elekta's Q2 presentation?

A recording of the webcast will be available on Elekta's website after the call.

ELEKTA B SHS UNSP/ADR

OTC:EKTAY

EKTAY Rankings

EKTAY Latest News

EKTAY Stock Data

2.80B
367.10M
0.01%
Medical Instruments & Supplies
Healthcare
Link
United States of America
Stockholm